228 related articles for article (PubMed ID: 36727249)
1. [Sero-epidemiological characteristics of the hepatitis D virus infection among hepatitis B virus infected-patients at a single center in Xinjiang region].
Zheng RJ; Talafu T; Deng ZR; Han D; Pan KJ; Lu XB
Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1044-1049. PubMed ID: 36727249
[No Abstract] [Full Text] [Related]
2. HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection.
Roggenbach I; Chi X; Lempp FA; Qu B; Walter L; Wu R; Gao X; Schnitzler P; Ding Y; Urban S; Niu J
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578380
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
[TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
[TBL] [Abstract][Full Text] [Related]
5. Characterization of hepatitis B and delta coinfection in Israel.
Shirazi R; Ram D; Rakovsky A; Bucris E; Gozlan Y; Lustig Y; Shaked-Mishan P; Picard O; Shemer-Avni Y; Ben-Zvi H; Halutz O; Lurie Y; Veizman E; Carlebach M; Braun M; Naftaly MC; Shlomai A; Safadi R; Mendelson E; Sklan EH; Ben-Ari Z; Mor O
BMC Infect Dis; 2018 Feb; 18(1):97. PubMed ID: 29486716
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of blood-borne viral infections in Afghanistan.
Husseini AA; Saeed KMI; Yurdcu E; Sertoz R; Bozdayi AM
Arch Virol; 2019 Aug; 164(8):2083-2090. PubMed ID: 31134354
[TBL] [Abstract][Full Text] [Related]
7. Characterization of hepatitis delta virus in sub-Saharan Africa.
Andernach IE; Leiss LV; Tarnagda ZS; Tahita MC; Otegbayo JA; Forbi JC; Omilabu S; Gouandjika-Vasilache I; Komas NP; Mbah OP; Muller CP
J Clin Microbiol; 2014 May; 52(5):1629-36. PubMed ID: 24599979
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of seronegative hepatitis D among patients with chronic viral hepatitis B].
Semenov AV
Zh Mikrobiol Epidemiol Immunobiol; 2012; (6):106-9. PubMed ID: 23297644
[TBL] [Abstract][Full Text] [Related]
9. A multicenter study of viral hepatitis in a United States hemophilic population.
Troisi CL; Hollinger FB; Hoots WK; Contant C; Gill J; Ragni M; Parmley R; Sexauer C; Gomperts E; Buchanan G
Blood; 1993 Jan; 81(2):412-8. PubMed ID: 7678517
[TBL] [Abstract][Full Text] [Related]
10. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis D virus infection among hepatitis B virus surface antigen positive individuals in Upper Egypt: Prevalence and clinical features.
Makhlouf NA; Morsy KH; Mahmoud AA
J Infect Public Health; 2019; 12(3):350-356. PubMed ID: 30833193
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of hepatitis D virus and its risk factors in the west of Iran.
Mohammad Alizadeh AH; Ranjbar M; Tehrani AS; Keramat F; Mamani M; Rezazadeh M; Aini P; Khalilian A; Majlesi A; Hajilooi M
J Microbiol Immunol Infect; 2010 Dec; 43(6):519-23. PubMed ID: 21195980
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
[TBL] [Abstract][Full Text] [Related]
14. Virological and clinical characteristics of hepatitis delta virus in South Asia.
Mumtaz K; Ahmed US; Memon S; Khawaja A; Usmani MT; Moatter T; Hamid S; Jafri W
Virol J; 2011 Jun; 8():312. PubMed ID: 21689416
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis D virus antibodies and liver function profile among patients with chronic hepatitis B infection in Abuja, Nigeria.
Abdulkareem LO; Ndububa DA; Uhunmwangho AO; Yunusa T
J Infect Dev Ctries; 2021 Jan; 15(1):141-146. PubMed ID: 33571156
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis D virus and hepatitis B virus infection in Amerindian communities of the Amazonas state, Colombia.
di Filippo Villa D; Cortes-Mancera F; Payares E; Montes N; de la Hoz F; Arbelaez MP; Correa G; Navas MC
Virol J; 2015 Oct; 12():172. PubMed ID: 26497287
[TBL] [Abstract][Full Text] [Related]
17. Population-based comparative epidemiological survey of hepatitis B, D, and C among Inuit migrated to Denmark and in high endemic Greenland.
Rex KF; Krarup HB; Laurberg P; Andersen S
Scand J Gastroenterol; 2012 Jun; 47(6):692-701. PubMed ID: 22229496
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological, clinical and histological characteristics of HBV/HDV co-infection: a retrospective cross-sectional study in Guangdong, China.
Liao B; Zhang F; Lin S; He H; Liu Y; Zhang J; Xu Y; Yi J; Chen Y; Liu H; Wang Z; Cai W
PLoS One; 2014; 9(12):e115888. PubMed ID: 25532128
[TBL] [Abstract][Full Text] [Related]
19. First molecular epidemiological study of hepatitis B and D in individuals infected with human T-lymphotropic virus 1/2 from Argentina.
Pataccini G; Berini CA; Pedrozo WR; Biglione MM; Delfino CM
J Med Virol; 2021 Jun; 93(6):3995-3998. PubMed ID: 32725912
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis delta in HIV/HBV co-infected patients in Brazil: is it important?
Mendes-Correa MC; Gomes-Gouvêa MS; Alvarado-Mora MV; Da Silva MH; Lázari C; Cavalcanti NC; Alonso FK; Carpinelli CC; Uip DE; Pinho JR
Int J Infect Dis; 2011 Dec; 15(12):e828-32. PubMed ID: 21999909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
